K-numberK254278
Device nameArterial Pressure Monitoring Set/Tray
ApplicantSpectrum Vascular
Product codeDQO
Device classClass II
Decision dateMar 25, 2026
DecisionSubstantially Equivalent
Regulation870.1200
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Arterial Pressure Monitoring Set/Tray is a sterile, single-use diagnostic intravascular catheter kit designed for continuous arterial blood pressure monitoring and blood sampling in adult and pediatric patients. It comprises a pressure monitoring catheter, wire guide, entry access needle, and syringe, inserted percutaneously via the Seldinger technique into arteries such as the radial, femoral, or distal aorta. Different catheter sizes (2.5 to 5.0 French) accommodate patients from birth through adults, with age-specific indications for each size.

Technological characteristics

The subject device is technologically identical to its predicate devices (K180846 and K180792) in all material, design, and performance aspects except for a change in marker ink formulation from UVA Ink (Color #1 Black) to UVA Ink (TPC 980 Black Ink). Both the primary and secondary predicates used identical catheter shaft materials (polyethylene, ethylene-vinyl acetate, polyurethane), single-lumen straight-tip design, stainless steel wire guides, EtO sterilization, and Tyvek-lidstock tray packaging with 10⁻⁶ sterility assurance level.

Test standards cited

The device was evaluated for biocompatibility in accordance with the ISO 10993 series. An additional ink legibility performance test was conducted to verify the new marker ink meets design requirements. No electrical safety, electromagnetic compatibility, or software testing was required, as the device contains no electrical components or software.

Substantial equivalence argument

Substantial equivalence is established because the subject device is identical to the primary (K180846) and secondary (K180792) predicate devices in intended use, indications for use, and all technological characteristics except the marker ink. The change to TPC 980 Black Ink was validated through biocompatibility testing per ISO 10993 and ink legibility performance testing, demonstrating that the new formulation maintains equivalent performance and does not alter the device's safety or effectiveness profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →